Page last updated: 2024-11-07

aminobenzyl-edta

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

aminobenzyl-EDTA: RN given refers to cpd without isomeric designation; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID134715
CHEMBL ID81013
SCHEMBL ID1742184
MeSH IDM0161280

Synonyms (16)

Synonym
CHEMBL81013
glycine, n,n'-(1-((4-aminophenyl)methyl)-1,2-ethanediyl)bis(n-(carboxymethyl)-
aminobenzyl-edta
84256-90-6
2,2',2'',2'''-{[3-(4-aminophenyl)propane-1,2-diyl]dinitrilo}tetraacetic acid
2-[[3-(4-aminophenyl)-2-[bis(carboxymethyl)amino]propyl]-(carboxymethyl)amino]acetic acid
FT-0648726
AKOS015889513
SCHEMBL1742184
RPBJIOJIMOUOIN-UHFFFAOYSA-N
1-(p-aminobenzyl)ethylenediaminetetraacetic acid
1-(4-aminobenzyl)ethylenediamine-n,n,n',n'-tetraacetic acid
aminobenzyl-edta, >=90% (chn)
2,2',2'',2'''-(3-(4-aminophenyl)propane-1,2-diyl)bis(azanetriyl)tetraacetic acid
DTXSID301004541
2-{[1-(4-aminophenyl)-3-[bis(carboxymethyl)amino]propan-2-yl](carboxymethyl)amino}acetic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID26719Biodistribution of labeled B72.3-chelator conjugate(EDTA isothiocynates) in Nude mice bearing LS174T tumors, in spleen, administered intravenously expressed as % of injected dose of indium-111 per gram of tissue1989Journal of medicinal chemistry, Jan, Volume: 32, Issue:1
Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting.
AID26718Biodistribution of labeled B72.3-chelator conjugate(EDTA isothiocynates) in Nude mice bearing LS174T tumors, in lungs, administered intravenously expressed as % of injected dose of indium-111 per gram of tissue1989Journal of medicinal chemistry, Jan, Volume: 32, Issue:1
Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting.
AID26504Biodistribution of labeled B72.3-chelator conjugate (EDTA isothiocynates) in Nude mice bearing LS174T tumor (Ag-), administered intravenously; ND is no data.1989Journal of medicinal chemistry, Jan, Volume: 32, Issue:1
Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting.
AID26505Biodistribution of labeled B72.3-chelator conjugate (EDTA isothiocynates) in Nude mice bearing LS174T tumors, in blood, administered intravenously expressed as % of injected dose of indium-111 per gram of tissue1989Journal of medicinal chemistry, Jan, Volume: 32, Issue:1
Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting.
AID26721Biodistribution of labeled B72.3-chelator conjugatec in Nude mice bearing LS174T tumor (Ag+), administered intravenously expressed as % of injected dose of indium-111 per gram of tissue1989Journal of medicinal chemistry, Jan, Volume: 32, Issue:1
Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting.
AID26720Biodistribution of labeled B72.3-chelator conjugate(EDTA isothiocynates) in nude mice bearing LS174T tumors, in kidney, administered intravenously expressed as % of injected dose of indium-111 per gram of tissue1989Journal of medicinal chemistry, Jan, Volume: 32, Issue:1
Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting.
AID26717Biodistribution of labeled B72.3-chelator conjugate(EDTA isothiocynates) in Nude mice bearing LS174T tumors, in liver, administered intravenously expressed as % of injected dose of indium-111 per gram of tissue1989Journal of medicinal chemistry, Jan, Volume: 32, Issue:1
Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.51

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.51 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.51)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]